$8,000$15,000+ per cycle (Standard) Up to $50,000 per cycle (Iconic) 13 day typical recovery All medical and travel costs covered
Ready to determine your options
Retatrutide is an investigational once-weekly triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide and tirzepatide
Adjustments are made based on clinical progress, laboratory markers, and reported symptom changes, allowing flare management strategies to evolve with the patients needs
Consult a doctor While most side effects of Ozempic (semaglutide) are mild and manageable, certain symptoms require immediate medical attention